Occurrence, Fate and Toxicity of Personal Care Products and Pharmaceuticals in Estuaries and Coastal Areas

A special issue of Toxics (ISSN 2305-6304). This special issue belongs to the section "Ecotoxicology".

Deadline for manuscript submissions: closed (15 April 2022) | Viewed by 3805

Special Issue Editor


E-Mail Website
Guest Editor
Department of Environmental Sciences, Informatics and Statistics, University Ca' Foscari Venice, 30172 Mestre-Venice, Italy
Interests: ecotoxicology; bioaccumulation; neonicotinoids; pharmaceuticals; personal care products; birds; toxicity testing with marine invertebrates

Special Issue Information

Dear Colleagues,  

The increasing evidence of the occurrence of emerging pollutants such as fragrance materials, insect repellents, UV filters, human and veterinary pharmaceuticals, and antibiotics in estuaries and coastal areas is a rising concern in the scientific community. Despite their widespread use and the growing evidence of their worldwide occurrence in surface waters, the knowledge of many of these pollutants' environmental fate and their toxic effects on brackish and marine species is still poor. In many cases, exposure and toxicity data are available only for a restricted number of compounds and most of the data concerns freshwater model organisms. Exposure and effects on estuarine and marine species were wholly overlooked, notwithstanding coastal areas and oceans being the final repository for most of the discharged personal care products and pharmaceuticals.

This Special Issue of Toxics aims to gather studies allowing the improvement of our overall knowledge on the following topics:

  • Occurrence and fate of personal care products and pharmaceuticals in estuaries and coastal environments;
  • Bioaccumulation of personal care products and pharmaceuticals in aquatic vertebrate and invertebrates;
  • Toxicity of personal care products and pharmaceuticals toward marine and estuarine species, including bacteria, algae, invertebrates and vertebrates, emphasising sub-lethal effects. Studies concerning biomarkers and in vivo and/or in vitro toxicity tests are welcome.

I encourage scientists to contribute with original research papers, reviews and short communications dealing with the above-mentioned topics.

I look forward to receiving your contributions.

Dr. Marco Picone
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Toxics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • personal care products
  • UV filters
  • fragrance materials
  • human pharmaceuticals
  • veterinary pharmaceuticals
  • toxicity testing
  • bioaccumulation
  • biomarker

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

23 pages, 14678 KiB  
Article
Towards the Development of Standardized Bioassays for Corals: Acute Toxicity of the UV Filter Benzophenone-3 to Scleractinian Coral Larvae
by Ingo B. Miller, Mareen Moeller, Matthias Y. Kellermann, Samuel Nietzer, Valentina Di Mauro, Elham Kamyab, Sascha Pawlowski, Mechtild Petersen-Thiery and Peter J. Schupp
Toxics 2022, 10(5), 244; https://doi.org/10.3390/toxics10050244 - 10 May 2022
Cited by 17 | Viewed by 3438
Abstract
Coral reefs have been declining globally at a historically unprecedented rate. Ultraviolet (UV) filters used in sunscreens may contribute to this decline at local scales, which has already led to bans on various organic UV filters in some regions. However, the underlying studies [...] Read more.
Coral reefs have been declining globally at a historically unprecedented rate. Ultraviolet (UV) filters used in sunscreens may contribute to this decline at local scales, which has already led to bans on various organic UV filters in some regions. However, the underlying studies for these bans demonstrated significant flaws in the experimental design due to a lack of validated and standardized testing methods for corals. This study aimed to investigate options for the development of a standard acute toxicity test for the larval stage of scleractinian corals. Planula larvae of two brooding (Leptastrea purpurea and Tubastraea faulkneri) and two spawning (Acropora digitifera and A. millepora) species were exposed to the organic UV filter benzophenone-3 (BP3) for 48 h under static conditions. We observed interspecific variations in toxicity, with A. digitifera being the most sensitive (LC50 = 0.75 µg L−1) and T. faulkneri the least sensitive (LC50 = 2951.24 µg L−1) species. Inhibition of settlement was found to be a useful endpoint leading to an EC50 of 1.84 µg L−1 in L. purpurea larvae. Although the analytical challenges of measuring lipophilic substances in small volume test setups remain, the here applied test design and selected endpoints are suitable for further validation and subsequent standardization. Full article
Show Figures

Figure 1

Back to TopTop